Coronavirus structural morphology

FOMAT Medical Research testing promising antibody cocktail ‘REGN-COV2’ to treat, prevent COVID-19

FOMAT Medical Research testing promising antibody cocktail ‘REGN-COV2’ to treat, prevent COVID-19

An antibody cocktail called REGN-COV2 designed to treat and prevent coronavirus infection is being tested at FOMAT Medical Research in Oxnard. FOMAT is launching two clinical trials for COVID-19 treatment, the disease caused by the SARS-COV-2, on Thursday, reported CBS Los Angeles.

Nicholas Focil, CEO at FOMAT, said the experimental treatment looks very much promising as it gives the body to fight it off on its own in a way. REGN-COV2 employs two antibodies to neutralize the coronavirus, hindering its infection of healthy cells.

According to the report, volunteers can get free coronavirus testing at a site across from the Oxnard Main Library – with results returning within an hour. Trial participants testing positive can take part in the study for treatment for COVID-19.

“This medication is for early onset. You are randomized into one of three arms. It’s a combination therapy that you will be in high dose, low dose or placebo. “It’s a single-day treatment; thereafter, you’ll receive follow-up appointments approximately 15 times over the next 35 days” Focil explained.

“This one depends on if you are in a household with somebody that has COVID. So what’s important with vaccines and preventative trials, in general, is that you have high exposure to the disease,” Focil said. This underscores the significance of robust testing protocols.

“The vaccine is around the corner. The treatment for COVID-19 is around the corner, and we do need the part of every single person here to make sure this thing gets through,” he added.

Focil notes that trial funding originates from the government’s “Operation Warp Speed,” striving for COVID-19 vaccine delivery by January 2021.

Source: Timesnownews

Contact Us

    Tags: No tags

    Add a Comment

    Your email address will not be published. Required fields are marked *